The Life Sciences D’n’A podcast is hosted by AI and data analytics experts and pharma industry veterans Nagaraja Srivatsan and Amar Drawid. They explore the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Putting Business Value at the Center of AI in Biopharma
Artificial intelligence may be moving quickly, but life sciences companies cannot afford to treat it as a race for the latest shiny tool. In this episode of Life Sciences DNA, Brinda Banerjee, CIO of Stemline Therapeutics, sits down with Srivatsan Nagaraja to discuss how an oncology-focused biopharma company can pursue AI with rigor, speed, and a clear connection to business and patient impact. Banerjee offers a practical framework for moving from enthusiasm to execution: start with the business problem, build trusted data and governance foundations, keep experts in the loop, and form agile, cross-functional teams that can test, learn, and scale what works.
24 Sept 2026
Turning Data and AI Into Better Business Outcomes
Artificial intelligence is reshaping how biopharmaceutical companies discover, develop, commercialize, and support medicines. But realizing its potential requires far more than adopting the latest tools. Srivatsan Nagaraja speaks with Matt Lasmanis, chief digital officer at Jazz Pharmaceuticals, about building a digital, data, and AI strategy grounded in corporate ambition and measurable outcomes. Lasmanis offers a practical framework that begins with strategy, identifies the business outcomes that matter most, and establishes the metrics needed to demonstrate progress. He also discusses how companies can align people, technology, and partners to build enterprise capabilities that advance precision, efficiency, and innovation.
10 Sept 2026
Measuring AI by Business Results in Life Sciences
Artificial intelligence is creating new opportunities to improve clinical development, but successful adoption requires more than choosing the latest model or launching isolated pilots. Krishna Cheriath, vice president and head of digital and AI for biopharma services at Thermo Fisher Scientific, sits down with Srivatsan Nagaraja to discuss what it takes to translate AI’s promise into measurable business and patient impact, why companies should focus on a small number of strategic imperatives, and his practical approach for prioritizing high-value use cases.
Who has been a guest on Life Sciences D’n’A
Names identified in recent episode analyses. Showing up to five guests.
Ariel Katz
Venky Iyer
Nagaraja Srivatsan
Scott Chetham
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
30,499
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
3 ratings
Spotify
5.0 / 5
2 ratings
Podcast Authority Score: 34 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
10
Social presence
0
YouTube
85
Engagement
60
Host of Life Sciences D’n’A?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
